WHO ICTRP trial
African leishmaniasis: From clinical research to access
PACTR202205775486864 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202205775486864 |
|---|---|
| Public title | African leishmaniasis: From clinical research to access |
| Scientific title | ‘A PHASE II/ III, OPEN LABEL, MULTICENTRE, RANDOMISED CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF THERMOTHERAPY FOR THE TREATMENT OF UNCOMPLICATED CUTANEOUS LEISHMANIASIS CASES’ |
| Primary sponsor | Armauer Hansen Research Institute |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase-3 |
| Countries | Ethiopia;Ethiopia;Ethiopia;Ethiopia |
| Conditions | Uncomplicated Cutaneous Leishmaniasis Skin and Connective Tissue Diseases;Uncomplicated Cutaneous Leishmaniasis ;Skin and Connective Tissue Diseases |
| Interventions | Local thermotherapy or heat therapy;Sodium Stibogluconate |
| Registration date | Jan 10, 2021 |
| Target size | 326 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: